Comparison between Captain Fresh IPO and Molbio Diagnostics IPO.
Captain Fresh IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Molbio Diagnostics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Captain Fresh IPO is up to ₹1,700.00 Cr whereas the issue size of the Molbio Diagnostics IPO is up to ₹0.00 Cr. The final issue price of Captain Fresh IPO is and of Molbio Diagnostics IPO is .
| Captain Fresh IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Face Value | ₹0 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 0 shares | 1,25,56,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹1,700.00 Cr | up to ₹0.00 Cr |
Captain Fresh IPO opens on , while Molbio Diagnostics IPO opens on . The closing date of Captain Fresh IPO and Molbio Diagnostics IPO is , and , respectively.
Captain Fresh IPO P/E ratio is , as compared to Molbio Diagnostics IPO P/E ratio of .
| Captain Fresh IPO | Molbio Diagnostics IPO | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials (Restated)Molbio Diagnostics Ltd.'s revenue increased by 22% and profit after tax (PAT) rose by 66% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.65 | |||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||
| ROE | 16.20% | |||||||||||||||||||||||||||||||||||
| ROCE | 20.98% | |||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | |||||||||||||||||||||||||||||||||||
| RoNW | 15.23% | |||||||||||||||||||||||||||||||||||
In the Captain Fresh IPO Retail Individual Investors (RII) are offered 0 shares while in Molbio Diagnostics IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Captain Fresh IPO and 0 shares in Molbio Diagnostics IPO.
| Captain Fresh IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Captain Fresh IPO subscribed in total, whereas Molbio Diagnostics IPO subscribed .
